| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 3.868 | 10.747 | 20.622 | 11.977 | 21.854 | 25.028 | 30.909 |
| Total Income - EUR | - | - | - | 3.868 | 10.747 | 20.622 | 11.977 | 21.856 | 25.028 | 31.115 |
| Total Expenses - EUR | - | - | - | 3.556 | 4.168 | 5.439 | 2.536 | 8.420 | 19.530 | 25.190 |
| Gross Profit/Loss - EUR | - | - | - | 312 | 6.579 | 15.183 | 9.441 | 13.437 | 5.498 | 5.925 |
| Net Profit/Loss - EUR | - | - | - | 196 | 6.257 | 14.564 | 9.082 | 12.781 | 5.248 | 4.994 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Miclaclinic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 973 | 1.084 | 1.961 | 902 | 25.749 | 20.919 | 15.452 |
| Current Assets | - | - | - | 386 | 5.501 | 19.259 | 28.772 | 17.707 | 21.949 | 19.330 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 420 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 502 | 0 | 0 | 0 | 0 |
| Cash | - | - | - | 386 | 5.501 | 18.757 | 28.772 | 17.287 | 21.949 | 19.330 |
| Shareholders Funds | - | - | - | 239 | 6.491 | 20.932 | 29.549 | 36.217 | 41.355 | 32.005 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 1.120 | 95 | 288 | 125 | 7.238 | 1.513 | 2.777 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Miclaclinic S.r.l.